BASF Pharma Solutions produces innovative excipients and active ingredients of outstanding quality and performance. With a global team of industry experts and digital solutions, BASF supports its customers in developing efficient, cost-effective and reliable formulations.
Equipped with an in-depth understanding of multiple technologies and applications, we have the knowledge and resources to make pharmaceutical drug delivery and the manufacturing of drugs and biologics safer and more sustainable. We create solutions for Biopharma, Parenteral, Oral, Solubilization and Topical applications and are also a leading supplier of selected APIs such as ibuprofen, L-menthol and Omega-3.
About BASF
At BASF, we create chemistry for a sustainable future. We combine economic success with environmental protection and social responsibility. Around 112,000 employees in the BASF Group contribute to the success of our customers in nearly all sectors and almost every country in the world. Our portfolio comprises six segments: Chemicals, Materials, Industrial Solutions, Surface Technologies, Nutrition & Care and Agricultural Solutions. BASF generated sales of €68.9 billion in 2023. BASF shares are traded on the stock exchange in Frankfurt (BAS) and as American Depositary Receipts (BASFY) in the United States. Further information at www.basf.com.
Credits: https://www.basf.com/en/tools/legal/credits.html
Data protection information: https://www.basf.com/global/en/legal/data-protection-at-basf.html
-
Branche
-
Arzneimittelherstellung
-
Größe
-
10.001+ Beschäftigte
-
Hauptsitz
-
Ludwigshafen am Rhein
-
Gegründet
-
1865
-
Spezialgebiete
-
Pharmaceutical Excipients, Active Pharmaceutical Ingredients, Omega-3 Fatty Acids, Solubilization, Skin Delivery, Biologic Solutions, Instant & Modified Release, Softgels, Regulatory Support, Safety, Technical Support, Product Formulation, compliance documentation, Topicals, Virtual Assistants, Orals, Omega 3 und BioPharma